CLINICAL RESEARCH IN CARDIOLOGY, vol.100, no.7, pp.571-577, 2011 (Journal Indexed in SCI)
Article / Article
CLINICAL RESEARCH IN CARDIOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated:
Levosimendan is a promising new inodilator agent but its effectiveness in peripartum cardiomyopathy (PPCM) has not been tested in a clinical trial. The authors sought to evaluate the effect of levosimendan therapy and to determine the predictors of clinical outcome in patients with PPCM.